GranuFlo and NaturaLyte Lawsuits
Individuals who received hemodialysis treatment with GranuFlo and NaturaLyte acid concentrates have reported experiencing serious side effects including heart attack and stroke. Fresenius Medical Care (FMC), the manufacturer of GranuFlo and NaturaLyte, is expected to face thousands of lawsuits from dialysis patients that have been injured by their product.
The Food and Drug Administration (FDA) issued a Class 1 recall of GranuFlo and NaturaLyte products in March 2012 based on evidence that the products can cause deadly side effects such as heart attack, myocardial infarction, stroke, cardiopulmonary arrest and sudden death among dialysis patients with elevated pre-dialysis bicarbonate levels.
This recall was sparked by a leaked internal memo from Fresenius Medical Care that warned about the connection between cardiac arrest and GranuFlo and NaturaLyte products. In their memo, FMC reported that patients with elevated bicarbonate levels who underwent hemodialysis treatment with GranuFlo or NaturaLyte products were 6 times more likely to suffer heart attacks than those receiving treatment with other dialysate acid concentrates. The manufacturer failed to offer the same warnings about GranuFlo and NaturaLyte to thousands of other physicians and dialysis clinics not owned by Fresenius.
If you or a loved one experienced side effects from hemodialysis treatment with GranuFlo or NaturaLyte, you may be eligible to file a lawsuit. Contact the dialysis injury attorneys at Hissey Kientz, LLP for a free case evaluation by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.